Skip to Main Content

Author Details

Brigid S Boland
University of California
2005
100
31
PMIDPaper TitleJournal TitlePublished Year
38052229Reverse metabolomics for the discovery of chemical structures from humans.Nature2024
38052229Reverse metabolomics for the discovery of chemical structures from humans.Nature2024
36343846Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.Clin Gastroenterol Hepatol2023
35704691A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's Disease.Inflamm Bowel Dis2023
35644340Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.Clin Gastroenterol Hepatol2023
36343846Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.Clin Gastroenterol Hepatol2023
36191274The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.Am J Gastroenterol2023
37853256Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation.Nat Biotechnol2023
37648857Metabolic programs of T cell tissue residency empower tumour immunity.Nature2023
37268795Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis.Dig Dis Sci2023
36623171Prevalence and Correlations of Gastrointestinal Symptoms With Endoscopic and Histologic Mucosal Healing in Crohn's Disease.Am J Gastroenterol2023
37061107HLA-DQA1⿿05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol2023
36993763A Living Organoid Biobank of Crohn's Disease Patients Reveals Molecular Subtypes for Personalized Therapeutics.bioRxiv2023
37235748Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.Inflamm Bowel Dis2023
36854061Identification of CD8 + T-Cell-Immune Cell Communications in Ileal Crohn's Disease.Clin Transl Gastroenterol2023
36986672The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.Pharmaceutics2023
36669515Management of inflammatory bowel diseases in older adults.Lancet Gastroenterol Hepatol2023
36662860A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy.Sci Adv2023
37224198Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.N Engl J Med2023
37853256Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation.Nat Biotechnol2023
37648857Metabolic programs of T cell tissue residency empower tumour immunity.Nature2023
35704691A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's Disease.Inflamm Bowel Dis2023
35644340Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.Clin Gastroenterol Hepatol2023
37061107HLA-DQA1⿿05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol2023
36993763A Living Organoid Biobank of Crohn's Disease Patients Reveals Molecular Subtypes for Personalized Therapeutics.bioRxiv2023
36986672The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.Pharmaceutics2023
37235748Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.Inflamm Bowel Dis2023
37268795Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis.Dig Dis Sci2023
37224198Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.N Engl J Med2023
36854061Identification of CD8 + T-Cell-Immune Cell Communications in Ileal Crohn's Disease.Clin Transl Gastroenterol2023
36623171Prevalence and Correlations of Gastrointestinal Symptoms With Endoscopic and Histologic Mucosal Healing in Crohn's Disease.Am J Gastroenterol2023
36669515Management of inflammatory bowel diseases in older adults.Lancet Gastroenterol Hepatol2023
36662860A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy.Sci Adv2023
36191274The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.Am J Gastroenterol2023
33039584Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.Clin Gastroenterol Hepatol2022
35973139Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.Am J Gastroenterol2022
35798960Enhancing untargeted metabolomics using metadata-based source annotation.Nat Biotechnol2022
33556578Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis.Clin Gastroenterol Hepatol2022
33039584Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.Clin Gastroenterol Hepatol2022
35347100Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies.Clin Transl Gastroenterol2022
35798960Enhancing untargeted metabolomics using metadata-based source annotation.Nat Biotechnol2022
35347100Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies.Clin Transl Gastroenterol2022
35973139Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.Am J Gastroenterol2022
33556578Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis.Clin Gastroenterol Hepatol2022
32348905Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.Clin Gastroenterol Hepatol2021
32348905Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.Clin Gastroenterol Hepatol2021
33745174Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' reply.Aliment Pharmacol Ther2021
33744307Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.Gastroenterology2021
33555517Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.Dig Dis Sci2021
33252124Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease.Inflamm Bowel Dis2021
  • 1 - 50 of 200

Recommended Authors

University of California San Diego
Career Start Year 2013
Number of shared co-authors 0
Western University
Career Start Year 2011
Number of shared co-authors 3
City of Hope National Medical Center
Career Start Year 2010
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 2010
Number of shared co-authors 4
Regeneron Pharmaceuticals
Career Start Year 2009
Number of shared co-authors 0
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 2
University of California San Diego, Veterans Affairs San Diego Healthcare System
Career Start Year 2009
Number of shared co-authors 9
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 6
Center for Drug Evaluation and Research
Career Start Year 2006
Number of shared co-authors 3
Western University
Career Start Year 2006
Number of shared co-authors 3
Institute of Clinical Molecular Biology, Kiel University
Career Start Year 2005
Number of shared co-authors 9
Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
Paris Center for Microbiome Medicine
Career Start Year 2004
Number of shared co-authors 8
University of Amsterdam, Cancer Center Amsterdam
Career Start Year 2004
Number of shared co-authors 4
German Cancer Research Center
Career Start Year 2002
Number of shared co-authors 5
Columbia University
Career Start Year 2002
Number of shared co-authors 3
David Geffen School of Medicine at university of california los angeles
Career Start Year 2002
Number of shared co-authors 10
Regeneron Pharmaceuticals Inc.
Career Start Year 2000
Number of shared co-authors 0
Royal Brisbane and Women's Hospital
Career Start Year 2000
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 2000
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 14
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1994
Number of shared co-authors 8
University of Calgary, 0 Hospital Drive NW
Career Start Year 1992
Number of shared co-authors 1
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE)
Career Start Year 1992
Number of shared co-authors 12
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg
Career Start Year 1991
Number of shared co-authors 2
The University of Michigan ann arbor
Career Start Year 1990
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1985
Number of shared co-authors 8
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 5
University of Newcastle
Career Start Year 1984
Number of shared co-authors 3
University of North Carolina at Chapel Hill
Career Start Year 1981
Number of shared co-authors 15

Collaborators

University of California San Diego
Co-authored papers 67
Feinberg School of Medicine Northwestern University
Co-authored papers 54
University of California San Diego
Co-authored papers 51
University of California San Diego
Co-authored papers 26
Mayo Clinic
Co-authored papers 15
Mayo Clinic College of Medicine and Science
Co-authored papers 13
Icahn School of Medicine at Mount Sinai
Co-authored papers 13
Dartmouth-Hitchcock Medical Center
Co-authored papers 13
Jill Roberts Center for IBD
Co-authored papers 12
Icahn School of Medicine at Mount Sinai
Co-authored papers 12
Lenox Hill Hospital
Co-authored papers 12
NYU Grossman School of Medicine
Co-authored papers 12
Co-authored papers 11
Schulich school of Medicine, Western University.
Co-authored papers 11
University of Minnesota
Co-authored papers 11
Co-authored papers 10
University of California
Co-authored papers 9
University of California San Francisco
Co-authored papers 8
Co-authored papers 6
Farncombe Family Digestive Health Research Institute, McMaster University
Co-authored papers 6
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences
Co-authored papers 6
Co-authored papers 5
F. Widjaja Inflammatory Bowel Disease Institute
Co-authored papers 5
Lahey Hospital and Medical Center
Co-authored papers 5
University of Alberta
Co-authored papers 5
Co-authored papers 4
University of California San Diego
Co-authored papers 4
Dartmouth-Hitchcock Medical Center
Co-authored papers 4
university of california san diego
Co-authored papers 4
University of California Irvine
Co-authored papers 4